Kezar Life Sciences has become the latest biotech to decide that it could do better than a buyout offer from Concentra Biosciences. Concentra’s parent company Tang Capital Partners has a track ...

1 Day CON 0.52% DJIA 0.09% S&P Mid Cap 400 0.01% Health Care/Life Sciences 0.22% ...

ADDISON, Texas--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation’s leader in occupational medicine, today announced the opening of a new medical center in Chattanooga, Tennessee. The medical ...

If you are an actively enrolled GCCIS student taking classes or a GCCIS faculty member, you will have access to Vmware software through Vmware on the Hub.

In a report released yesterday, David S Macdonald from Truist Financial maintained a Buy rating on Concentra Group Holdings Parent, Inc. (CON – Research Report), with a price target of $29.00.

Funded through the generous support of the Lilly Endowment as part of the Charting the Future initiative, the Innovation Hub focuses on course-based innovations at scale. With $5M in support, the ...

(RTTNews) - Kezar Life Sciences (KZR) announced that its Board has rejected the unsolicited, non-binding proposal from Concentra Biosciences, to acquire all of the outstanding shares of common ...

Earlier on Thursday, Kezar Life Sciences rejected the previously disclosed unsolicited, non-binding proposal from Concentra Biosciences for cash consideration of $1.10 per share, plus a contingent ...

ADDISON, Texas, October 07, 2024--Concentra® (NYSE: CON), the nation’s leader in occupational medicine, today announced the opening of a new medical center in Orlando, Florida. The medical ...